Gavi, the Vaccine Alliance, and Bavarian Nordic A/S have announced a significant advance purchase agreement, securing 500,000 doses of the MVA-BN® mpox vaccine for African countries affected by the ongoing mpox outbreak. The vaccine, marketed under various names including JYNNEOS® and IMVANEX®, will be delivered in 2024. In a statement on Wednesday, Gavi said the [...]
Related Articles
Don't miss out on breaking stories and in-depth articles.